Insiilco Medicine: Steven Galson, independent director
The AI-powered drug discovery firm has named Steven Galson as independent member of its board of directors. Recently retired from his executive position at Amgen, Galson also served as acting US Surgeon General of the from October 2007 to October 2009.
“Steven Galson is one of the world's most respected pharmaceutical industry executives and public health physicians who are dedicated to delivering effective drugs for the patients worldwide faster, cheaper, and safer,” said Alex Zhavoronkov, CEO and founder of Insilico Medicine. “He is also an expert in regulatory affairs and understands the importance of disruptive innovation at every research and development stage.”